News
Zacks Investment Research on MSN14h
AZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder CancerAstraZeneca AZN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) rendered ...
AstraZeneca (NASDAQ:AZN) announced Tuesday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback